Cargando…

Baculovirus Vectors for Gene Therapy

Since the discovery that baculoviruses can efficiently transduce mammalian cells, baculoviruses have been extensively studied as potential vectors for both in vitro and in vivo gene therapy. This chapter reviews the history of this research area, cells permissive to baculovirus transduction, factors...

Descripción completa

Detalles Bibliográficos
Autor principal: Hu, Yu‐Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112335/
https://www.ncbi.nlm.nih.gov/pubmed/16997015
http://dx.doi.org/10.1016/S0065-3527(06)68008-1
_version_ 1783513460130185216
author Hu, Yu‐Chen
author_facet Hu, Yu‐Chen
author_sort Hu, Yu‐Chen
collection PubMed
description Since the discovery that baculoviruses can efficiently transduce mammalian cells, baculoviruses have been extensively studied as potential vectors for both in vitro and in vivo gene therapy. This chapter reviews the history of this research area, cells permissive to baculovirus transduction, factors influencing transduction and transgene expression, efforts to improve transduction, mechanisms of virus entry and intracellular trafficking, applications for in vivo and ex vivo gene therapy, as well as advantages, limitations, and safety issues concerning use of baculoviruses as gene therapy vectors. Recent progress and efforts directed toward overcoming existing bottlenecks are emphasized.
format Online
Article
Text
id pubmed-7112335
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71123352020-04-02 Baculovirus Vectors for Gene Therapy Hu, Yu‐Chen Adv Virus Res Article Since the discovery that baculoviruses can efficiently transduce mammalian cells, baculoviruses have been extensively studied as potential vectors for both in vitro and in vivo gene therapy. This chapter reviews the history of this research area, cells permissive to baculovirus transduction, factors influencing transduction and transgene expression, efforts to improve transduction, mechanisms of virus entry and intracellular trafficking, applications for in vivo and ex vivo gene therapy, as well as advantages, limitations, and safety issues concerning use of baculoviruses as gene therapy vectors. Recent progress and efforts directed toward overcoming existing bottlenecks are emphasized. Elsevier Inc. 2006 2006-09-22 /pmc/articles/PMC7112335/ /pubmed/16997015 http://dx.doi.org/10.1016/S0065-3527(06)68008-1 Text en Copyright © 2006 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Hu, Yu‐Chen
Baculovirus Vectors for Gene Therapy
title Baculovirus Vectors for Gene Therapy
title_full Baculovirus Vectors for Gene Therapy
title_fullStr Baculovirus Vectors for Gene Therapy
title_full_unstemmed Baculovirus Vectors for Gene Therapy
title_short Baculovirus Vectors for Gene Therapy
title_sort baculovirus vectors for gene therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112335/
https://www.ncbi.nlm.nih.gov/pubmed/16997015
http://dx.doi.org/10.1016/S0065-3527(06)68008-1
work_keys_str_mv AT huyuchen baculovirusvectorsforgenetherapy